Anti-CD79B antibodies and immunoconjugates and methods of use
US10544218B2 · kind B2 · utility
3Cited by
126References
61Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2016 |
| Grant date | Jan 28, 2020 |
| Priority date | — |
| Expiry date | Nov 11, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.